Come and work with me and use the 53,897 samples of M. tuberculosis we have collated to help tackle this important disease! We are part of the OxCoD4TB consortium that is developing new therapeutics for tuberculosis. Grade 7, funding until 28 Feb 2028, deadline noon Fri 4 July bit.ly/4ndKOhF

@vbrunner.bsky.social doing her pitch for her poster at #ESMyco! @modmedmicro.bsky.social

Thrilled to have returned to the Congress of @escmid.bsky.social this year in the beautiful city of Vienna, and to have had the opportunity to present my latest work on rifampicin-resistant subpopulations in M. tuberculosis. 📋 Find all the details in our preprint: 🔗👇 www.biorxiv.org/content/10.1...

Another busy day at #ESCMIDGlobal! 0906 @vbrunner.bsky.social “RIF and subpopulations in TB” 0918 Ruan Spies “comparing TB pipelines" both in Hall 5 1000 Nicole Stoesser “plasmids & 1Health” in H2 1509 Jane Wei in Hall 2 “CAP and EHR” P1405 - Valentina Pennetta P2242 - Junko Takada

📢 Our preprint on rifampicin resistant subpopulations in clinical samples of M. tuberculosis has just been uploaded. We show how detection of resistant subpopulations can significantly improve WGS-based resistance prediction, and how they can help identify the source of resistance.

Check out @vbrunner.bsky.social latest work! Just in time for #ESCMIDGlobal and her talk next Monday morning.

Our amazing @modmedmicro.bsky.social team, who are leading our efforts to tackle antimicrobial resistance #AMR – in the lab, with data and in software - went blue for this picture for #WAAW2024. See more about our research at bashthebug.net

Researchers in @modmedmicro.bsky.social are studying the DNA of bacteria to understand the genes they carry and how they are related. This can help us detect outbreaks and track how antimicrobial resistance genes spread, so we can contain them better #WAAW2024

Come and work with us! Programme Manager is a key central role that sets large strategic objectives and manages practical issues across the MMM Unit. Grade 9, £55,636 - £64,228, deadline noon 6 Jan 25 bit.ly/4fGgnwv